Shadow Foundr’s investment campaign for Fertility Focus has been extended until Monday 16th July. The company’s revolutionary, patented product, Ovusense, which doubles the chances of conception each month, continues to enjoy record sales during the first half of 2018.
Shadow Foundr’s latest investment campaign for Fairmoney®, a company which is set to revolutionize the UK Loans Comparison sector, has got off to a promising start, with nearly £150k committed in the first few weeks.
Convert is a highly specialised and disruptive company with a mission to design and develop innovative technology for a range of industries focused on the HiFi, Home Entertainment, Sports, Wearable, Health and Logistics Sectors.
Shadow Foundr’s latest investment campaign for FairMoney.com, a company which is set to revolutionize the UK Loans Comparison sector, has got off to a flyer, with £118k committed in the first week alone.
On the back of this week’s positive news that online education platform, Pluralsight, has just raised over $310m through its IPO at an implied valuation of $1.97bn, Shadow Foundr’s campaign to raise funds for another leading Ed Tech business, Shaw Academy, is drawing ...Read More
Shadow Foundr is delighted to announce that one of the companies it has raised for, LIfT BioSciences, has been awarded Best Rising Start-Up at BioVaria 2018 by an experienced panel of judges, comprising major Pharma Companies, Venture Capital Firms & NGOs.Read More
Genesis’ broadband solution for enterprise customers, known for delivering low-cost superfast bandwidth over existing networks, shortlisted for Connected Britain award.Read More
Fertility Focus, the fertility technology experts behind OvuSense, a revolutionary, patented product which doubles the chances of conception each month, sold more units than ever before in April and its enjoyed its highest ever ...Read More